user

FIRST RUSSIAN TYPE 2 DIABETES MELLITUS SIMULATION MODEL WITH DISCRETE EVENTS MODELING. HEALTH-ECONOMIC ANALYSIS

被引：0
|
作者：
Kolbin, A. [1 ]
Kurylev, A. [1 ]
Balykina, Y. [1 ]
Proskurin, M. [1 ]
机构：
[1] St Petersburg State Univ, St Petersburg 199034, Russia
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.659
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A437 / A438
页数：2
相关论文
共 50 条
  • [41] Early glycemic control improves health and economic benefits in type 2 diabetes: A model based analysis
    Eddy, D
    Schlessinger, L
    Patwardhan, RN
    VALUE IN HEALTH, 2005, 8 (06) : A16 - A16
  • [42] Impact of HBAIC in type 2 diabetes mellitus in Mexico:: Simulation analysis, a pharmacoeconomic perspective
    Castañeda, R. C. L.
    Sil, M. J. S. A.
    Acevedo, G. A. R.
    Manterola, S. O. M. C.
    Ramirez, J. R.
    Rios, L. R. N.
    Romero, S. R.
    Barquera, S. B.
    VALUE IN HEALTH, 2007, 10 (06) : A266 - A266
  • [43] Predictive Modeling for presumptive diagnosis of Type 2 Diabetes Mellitus based on symptomatic analysis
    Barrios, Ordonez
    Alberto, Diego
    Infantes, Vizcarra
    Raphael, Erick
    Aguirre, Armas
    Alexander, Jimmy
    PROCEEDINGS OF THE 2017 IEEE XXIV INTERNATIONAL CONFERENCE ON ELECTRONICS, ELECTRICAL ENGINEERING AND COMPUTING (INTERCON), 2017,
  • [44] Economic model of first-line drug strategies to achieve recommended glycaemic control in newly diagnosed type 2 diabetes mellitus
    Ramsdell, JW
    Braunstein, SN
    Stephens, JM
    Bell, CF
    Botteman, MF
    Devine, ST
    PHARMACOECONOMICS, 2003, 21 (11) : 819 - 837
  • [45] Economic Model of First-Line Drug Strategies to Achieve Recommended Glycaemic Control in Newly Diagnosed Type 2 Diabetes Mellitus
    Joe W. Ramsdell
    Seth N. Braunstein
    Jennifer M. Stephens
    Christopher F. Bell
    Marc F. Botteman
    Scott T. Devine
    PharmacoEconomics, 2003, 21 : 819 - 837
  • [46] The health-economic impact of urine albumin-to-creatinine ratio testing for chronic kidney disease in Japanese patients with type 2 diabetes
    Asahi, Koichi
    Konta, Tsuneo
    Tamura, Kouichi
    Tanaka, Fumitaka
    Fukui, Akira
    Nakamura, Yusuke
    Hirose, Junichi
    Ohara, Kenichi
    Shijoh, Yoko
    Carter, Matthew
    Meredith, Kimberley
    Harris, James
    Akerborg, Orjan
    Kashihara, Naoki
    Yokoo, Takashi
    JOURNAL OF DIABETES INVESTIGATION, 2025, 16 (01) : 108 - 119
  • [47] QUALITY OF CARE FOR PATIENTS WITH DIABETES MELLITUS TYPE 2 IN 'MODEL PRACTICES' IN SLOVENIA - FIRST RESULTS
    Petek, Davorina
    Mlakar, Mitja
    ZDRAVSTVENO VARSTVO, 2016, 55 (03): : 179 - 184
  • [48] Health and economic effects on patients with type 2 diabetes mellitus in the long run: predictions for the Chilean population
    Antonio Espinoza, Manuel
    Abbott, Tomas
    Passi, Alvaro
    Balmaceda, Carlos
    DIABETOLOGY & METABOLIC SYNDROME, 2022, 14 (01):
  • [49] Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis
    Gaebler, Julia A.
    Soto-Campos, Gerardo
    Alperin, Peter
    Cohen, Marc
    Blickensderfer, Amy
    Wintle, Matthew
    Maggs, David
    Hoogwerf, Byron
    Han, Jenny
    Pencek, Richard
    Peskin, Barbara
    VASCULAR HEALTH AND RISK MANAGEMENT, 2012, 8 : 255 - 264
  • [50] Estimation of the economic and health impact of complications of type 2 diabetes mellitus in the autonomous community of Madrid (Spain)
    Arrieta, Francisco
    Rubio-Terres, Carlos
    Rubio-Rodriguez, Dario
    Magana, Ana
    Pinera, Marbella
    Iglesias, Pedro
    Nogales, Pedro
    Calanas, Alfonso
    Novella, Blanca
    Ignacio Botella-Carretero, Jose
    Deban, Carlos
    Zamarron, Isabel
    Mora, Gustavo
    Antonio Balsa, Jose
    Vazquez, Clotilde
    ENDOCRINOLOGIA Y NUTRICION, 2014, 61 (04): : 193 - 201
12345